English
 
User Manual Privacy Policy Disclaimer Contact us
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Poster

Genetic factors influencing the development of binding and neutralizing antibodies against interferon beta treatment in multiple sclerosis patients

MPS-Authors
/persons/resource/persons125664

Andlauer,  T.F.M.
Max Planck Institute of Psychiatry, Max Planck Society;

/persons/resource/persons80450

Mueller-Myhsok,  B.
RG Statistical Genetics, Dept. Translational Research in Psychiatry, Max Planck Institute of Psychiatry, Max Planck Society;

Locator
There are no locators available
Fulltext (public)
There are no public fulltexts available
Supplementary Material (public)
There is no public supplementary material available
Citation

Andlauer, T., andlauer, t, Link, J., Buck, D., Ryner, M., Grummel, V., et al. (2018). Genetic factors influencing the development of binding and neutralizing antibodies against interferon beta treatment in multiple sclerosis patients. Poster presented at 34th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (ECTRIMS), Berlin, GERMANY.


Cite as: http://hdl.handle.net/21.11116/0000-0003-6FA7-5
Abstract
There is no abstract available